BD" Mouse IgG2a Isotype Control APC X39 ASR

FDA Device Recall #Z-2333-2021 — Class II — July 22, 2021

Recall Summary

Recall Number Z-2333-2021
Classification Class II — Moderate risk
Date Initiated July 22, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Becton, Dickinson and Company, BD Biosciences
Location San Jose, CA
Product Type Devices
Quantity 23 reagents

Product Description

BD" Mouse IgG2a Isotype Control APC X39 ASR

Reason for Recall

Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive staining due to contamination with another antibody.

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution in the states of CT, FL, KY, NY, and PA. The country of Taiwan.

Lot / Code Information

Catalog Number: 340757 UDI: 00382903407576 Lot Number: 0253432

Other Recalls from Becton, Dickinson and Company, BD Bio...

Recall # Classification Product Date
Z-2351-2024 Class II BD Multitest 6-Color TBNK CE-IVD, REF: 644611; ... May 8, 2024
Z-0641-2024 Class II CD11b APC: ASR, REF: 340936, and CE, REF: 333143 Oct 25, 2023
Z-0173-2023 Class II BD Multitest 6-Color TBNK with optional BD Truc... Oct 3, 2022
Z-0171-2023 Class II BD Trucount Tubes (Cat. No. 340334), used for d... Oct 3, 2022
Z-0172-2023 Class II BD Trucount Tubes (Cat. No. 663028), used for d... Oct 3, 2022

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.